STIM
Neuronetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.71
+19.69%Nov 4, 2026, 21:30 UTC
Neuronetics granted inducement awards to 14 non-executive employees under NASDAQ, INC. Listing Rule 5635(c)(4).
Source:Nov 4, 2026, 16:06 UTC
Neuronetics, Inc. reported a quarterly loss of $0.02 per share, compared with a Zacks Investment Research, Inc. Consensus Estimate of a $0.08 loss and a loss of $0.13 per share a year earlier.
Source:Nov 4, 2026, 12:50 UTC
Neuronetics announced its financial and operating results for the third quarter of 2026.
Source:Oct 21, 2026, 12:30 UTC
Neuronetics announced that it plans to release its third-quarter 2026 financial and operating results before market open on November 4, 2026.
Source:Sep 8, 2026, 12:32 UTC
Neuronetics announced the integration of its TrakStar practice management platform with AdvancedMD, marking the first-ever TMS integration with an EHR/EMR system.
Source:Aug 17, 2026, 00:00 UTC
Nir Naor was appointed Executive Vice President, Chief Financial Officer, and Treasurer of Neuronetics, Inc., effective July 23, 2026, and subsequently became principal financial and accounting officer on August 12, 2026, succeeding Francis X. Brown III as interim principal financial and accounting officer.
Aug 11, 2026, 16:05 UTC
Neuronetics introduced additional commercial purchasing options for its NeuroStar transcranial magnetic stimulation (TMS) systems.
Source:Aug 11, 2026, 11:50 UTC
Neuronetics, Inc. announced its financial and operating results for the second quarter of 2026, reporting total revenue of $41.6 million, up 9.1% year-over-year, and a net loss of $3.4 million.